Silvan Tuerkcan analyst

Currently out of the existing stock ratings of Silvan Tuerkcan, 137 are a BUY (97.86%), 3 are a HOLD (2.14%).

Silvan Tuerkcan

Work Performance Price Targets & Ratings Chart

Analyst Silvan Tuerkcan, carries an average stock price target met ratio of 48.38% that have a potential upside of 49.39% achieved within 130 days. Previously, Silvan Tuerkcan worked at JMP.

Silvan Tuerkcan’s has documented 272 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BNTC, Benitec Biopharma Ltd ADR at 18-Mar-2025.

Wall Street Analyst Silvan Tuerkcan

Analyst best performing recommendations are on LOGC (LOGICBIO THERAPEUTICS).
The best stock recommendation documented was for MRTX (MIRATI THER) at 9/28/2023. The price target of $58 was fulfilled within 7 days with a profit of $12.65 (27.89%) receiving and performance score of 39.85.

Average potential price target upside

EXEL Exelixis LOGC LogicBio Therapeutics MGNX MacroGenics NTLA Intellia Therapeutics RLAY Relay Therapeutics  TPTX Turning Point Therapeutics TSHA Taysha Gene Therapies  CLLS Cellectis SA GBIO Generation Bio Co MRTX Mirati Ther SGEN Seagen CRSP Crispr Therapeutics AG VOR Vor Biopharma CNST Constellation Pharmaceuticals TERN Terns Pharmaceuticals BNTC Benitec Biopharma Ltd ADR MNDY Monday.Com Ltd JSPR Jasper Therapeutics ELEV Elevation Oncology

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$3.3 (8.99%)

$40

4 days ago
(27-Mar-2025)

4/8 (50%)

$3.16 (8.58%)

162

Buy

$40

$3.3 (8.99%)

$34

18 days ago
(13-Mar-2025)

8/9 (88.89%)

$3.2 (8.70%)

159

Buy

$36

$-0.7 (-1.91%)

$36

1 months 7 days ago
(24-Feb-2025)

2/3 (66.67%)

$-0.85 (-2.31%)

144

Hold

$29

$-7.7 (-20.98%)

$25

1 months 18 days ago
(13-Feb-2025)

6/7 (85.71%)

$-5.49 (-15.92%)

961

Buy

$45

$8.3 (22.62%)

$31

1 months 19 days ago
(12-Feb-2025)

1/2 (50%)

$12.2 (37.20%)

320

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Silvan Tuerkcan is most bullish on?

Potential upside of $49.01 has been obtained for CRSP (CRISPR THERAPEUTICS AG)

Which stock is Silvan Tuerkcan is most reserved on?

Potential downside of -$0 has been obtained for MGNX (MACROGENICS)

What Year was the first public recommendation made by Silvan Tuerkcan?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?